Anterior Uveitis Treatment Market Is Booming Worldwide | Soliris, Pfizer, AbbVie

The Anterior Uveitis Treatment Market in 2024 is experiencing significant growth, driven by the increasing incidence of anterior uveitis, advancements in diagnostic imaging, and expanding therapeutic options to manage inflammation and preserve vision in affected individuals. Anterior uveitis, also known as iritis, is characterized by inflammation of the iris and other structures in the front… Continue reading Anterior Uveitis Treatment Market Is Booming Worldwide | Soliris, Pfizer, AbbVie